Assems Inc (136410) Fair Value & Analysis
Basic Materials · KR · Market cap 48.6B KRW
Fair value as of: Jul 20, 2026
From 24 valuation models · updated today
Share price −15.2% over the past month.
Price vs Fair Value (12 months)
12‑month range 4,640 KRW – 12,015 KRW · fair‑value band 4,756 KRW – 10,419 KRW · the 4,640 KRW price screens below the 6,699 KRW fair value. As of Jul 20, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Assems Inc (136410) currently trades at 4,640 KRW, while our model-based Fair Value estimate is 6,699 KRW, implying the stock looks roughly 44.4% undervalued today. We read business quality at 51/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Assems Inc generated revenue of 56.8B KRW at a net margin of 13.6%. Revenue declined 20.9% year over year. It earns a return on equity of 11.1%. Net debt stands at 16.6B KRW. Fundamentals as of Jul 20, 2026
Our scenario range runs from 4,756 KRW (bear case) to 10,419 KRW (bull case); at 4,640 KRW, the current price sits below that range. The share trades about 62% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -54% fair-value upside, at 44%, 136410 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 20, 2026. TTM = trailing twelve months.
About the company
Assems Inc. develops and sells adhesives in South Korea. The company produces hot-melt films. It also engages in laminating and coating of fabrics; development and production of adhesive textile; and production of hot-melt laminating machine. In addition, the company provides U-WEB, an air-permeable lamination sheet. Assems Inc. was founded in 2003 and is headquartered in Busan, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Assems Inc reported revenue of 60.3B KRW in FY2025 versus 42.0B KRW in FY2021, a compound +9.4%/yr. Reported net income was 8.8B KRW in FY2025, compounding +13.3%/yr from FY2021.
Is 136410 fairly valued? → Check now
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $509.16 | $159.69 | -69% |
| Nan Ya Plastics Corporation 1303 | 104.50 TWD | 4.87 TWD | -95% |
| Intercontinental Exchange, Inc I1CE34 | R$367.00 | R$311.38 | -15% |
| Wanhua Chemical Group 600309 | ¥74.30 | ¥68.03 | -8% |
| Novozymes A/S NSISB | kr 392.30 | kr 179.63 | -54% |
| PPG Industries, Inc P1PG34 | R$294.30 | R$152.53 | -48% |
| Asian Paints Limited ASIANPAINT | ₹2,674 | ₹739.38 | -72% |
| Solar Industries India Limited SOLARINDS | ₹17,697 | ₹2,793 | -84% |
| Pidilite Industries Limited PIDILITIND | ₹1,507 | ₹393.58 | -74% |
| PT Chandra Asri Pacific Tbk TPIA | 1,955 IDR | 2,350 IDR | +20% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Assems Inc (136410) undervalued?
What is the fair value of 136410?
What is the quality score of 136410?
What is the revenue of Assems Inc (136410)?
What is the net profit margin of 136410?
Does Assems Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when Assems Inc reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of Assems Inc materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.